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We examined the reservoir potential of white-tailed
deer for Anaplasma phagocytophilum. Results suggest that
white-tailed deer harbor a variant strain not associated with
human infection, but contrary to published reports, white-
tailed deer are not a reservoir for strains that cause human
disease. These results will affect surveillance studies of
vector and reservoir populations.
A
naplasma phagocytophilum is an obligate intracellular
bacterium and the etiologic agent of human granulo-
cytic anaplasmosis (formerly known as human granulocyt-
ic ehrlichiosis). From 1999 to 2003, a total of 1,686 cases
of human anaplasmosis were reported in the United States,
and >95% of these cases occurred in northeastern or upper
midwestern states. Transmission within and between reser-
voir populations in these regions occurs by Ixodes scapu-
laris ticks (1,2). Infections occur in humans who have been
fed upon by infected nymphal or adult ticks. No evidence
shows that A. phagocytophilum is transmitted transovarial-
ly within the tick population; thus, both infected reservoirs
and ticks that can transmit the infection must be available
to maintain the agent in nature. Three mammalian species
are reservoir competent: the white-footed mouse
(Peromyscus leucopus), raccoon (Procyon lotor), and gray
squirrel (Sciurus carolinensis), although serologic and
molecular evidence has suggested that numerous other
small, medium, and large mammals may also be reservoirs
(1,3).
Every examined A. phagocytophilum sample from a
patient with a confirmed case of human granulocytic
anaplasmosis from the northeastern or upper midwestern
United States has shown identical 16S rRNA sequences.
This sequence, referred to as the A. phagocytophilum
human anaplasmosis (AP-ha) signature sequence, differs
by 2 bp from the sequence of the 16S rRNAgene of a vari-
ant strain, AP-Variant 1. Recent studies that compared the
prevalence of AP-ha to AP-Variant 1 in tick populations
showed the variant to be the predominant strain at 2 of 3
sites and suggest that AP-Variant 1 is common in nature
(4,5).
The white-footed mouse serves as a natural reservoir
for AP-ha, and laboratory studies have shown that numer-
ous inbred strains of mice (e.g., Balb/C, C3H, DBA/2) are
also highly susceptible to infection (1,6,7). In contrast, AP-
Variant 1 does not infect the white-footed mouse, DBA/2,
and severely immunocompromised (SCID) mice (8).
These results suggest that rodents are not a natural reser-
voir for AP-Variant 1 and that alternative reservoir species
exist in nature. Previous reports have identified 3 white-
tailed deer (Odocoileus virginiansus) from Maryland and 2
white-tailed deer in Wisconsin that harbored an agent with
a 16S rRNA gene sequence identical to that of AP-Variant
1 (4,9,10). Several previous studies have also suggested
that white-tailed deer are a reservoir for the human agent
AP-ha (10–12). These results led to the current study,
which was conducted to investigate the relative potential
for white-tailed deer to be a reservoir for AP-ha, AP-
Variant 1, or both strains. We examined blood samples
from white-tailed deer to determine the strains of A.
phagocytophilum with which these deer were infected and
the ticks feeding on these deer to identify strains to which
they were exposed.
The Study
I. scapularis ticks were collected from white-tailed deer
during controlled hunts at Ridley Creek State Park in
Delaware County, Pennsylvania, in December of 2000,
2001, and 2002. Blood samples were also collected from
the deer in 2001 and 2002. An unusually high percentage
of ticks collected in December 2000 were positive for A.
phagocytophilum (68 [49.6%] of 137); identification was
based on polymerase chain reaction (PCR) amplification
of a 546-bp portion of the 16S rRNA gene, as previously
described (Table) (9). Further analysis showed a strong
correlation between the sex of a tick and the probability of
being positive for A. phagocytophilum. Most of the posi-
tive ticks were females; 62 (84.9%) of the 73 female ticks
were positive, compared with 6 (9.4%) of 64 males. DNA
sequencing of the PCR products showed that 53 (85.5%)
of the 62 PCR-positive females harbored AP-Variant 1,
while only 9 (14.5%) of 62 were infected with AP-ha.
Blood samples were not collected from white-tailed deer in
2000.
In 2001, both ticks and white-tailed deer blood samples
were collected. Similar to the year 2000 tick results, a
higher percentage of female ticks (50 [38.8%] of 129) than
male ticks (13 [20%] of 65) were positive for A. phagocy-
tophilum. Likewise, DNA sequencing showed that more
infected female ticks were positive for AP-Variant 1 (74%)
than for AP-ha (26%). Of the 38 white-tailed deer blood
samples collected in 2001, 11 (28.9%) were positive for
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positive for AP-ha. Most of the AP-Variant 1–positive ticks
were obtained from positive white-tailed deer, and AP-
Variant 1–positive ticks were collected from 8 of 11 posi-
tive deer. Of the 3 positive deer on which AP-Variant
1–positive ticks were not found, 1 deer had only 3 male
ticks collected, the second had only 2 males collected, and
the third had no ticks. Because adult male ticks do not take
a blood meal, we were not surprised that these AP-Variant
1–positive deer had no positive ticks.
The collection of samples in December 2002 resulted in
very few ticks (n = 6) because low temperatures inhibited
tick activity. PCR amplification and DNAsequencing of A.
phagocytophilum from female ticks (n = 4) showed that 1
tick was positive for AP-Variant 1 and 1 tick was positive
for AP-ha (Table). Only 1 of the 2 males that were collect-
ed was positive for A. phagocytophilum, which sequencing
showed to be AP-ha. Blood samples were collected from
24 white-tailed deer in 2002, and 5 (20.8%) of these were
positive for A. phagocytophilum. Each of these 5 positive
samples was AP-Variant 1.
Conclusions
The differential between the high percentage of AP-
Variant 1–positive female ticks (range 25%–72.6%) and
the relatively low number of male ticks positive for the
variant (<15.4%), combined with the fact that deer were
positive for only the variant, suggest that these partially
and fully engorged female ticks were acquiring AP-Variant
1 as they fed on the deer. The presence of AP-ha in both
male and female ticks that were feeding on deer showed
that these deer were frequently exposed to AP-ha. Despite
this demonstrated exposure to AP-ha, infections by AP-ha
in white-tailed deer were not found. These results suggest
that white-tailed deer are a natural reservoir for the variant,
and further, that white-tailed deer are not a reservoir for
AP-ha strains. These results also suggest that previous
serologic studies that identified white-tailed deer as a
reservoir for AP-ha strains were likely the result of the
cross-reactivity of the anti-AP-Variant 1 serum from deer
with the AP-ha antigens used for detection (10–12). In fact,
in a study in which serologic testing showed that 8% of
white-tailed deer in Wisconsin were positive for A. phago-
cytophilum, the only 2 samples that were PCR amplified
and sequenced were identical to AP-Variant 1 (10). Strong
antigenic cross-reactivity of the AP-ha and AP-Variant 1
strains would not be surprising, considering their 16S
rRNA genes are >99% identical. 
Seroprevalence studies for infectious agents using ani-
mal reservoir and host populations and PCR amplifications
from vector species are commonly used to assess the dis-
ease risk for humans in a particular region, particularly for
viral and bacterial zoonotic agents. Our results show that
animal seroprevalence studies for A. phagocytophilum
must be carefully evaluated to determine whether the agent
inducing the immune response is truly infectious in
humans. Our results further show that while PCR studies
of ticks may identify A. phagocytophilum, DNA sequenc-
ing of the PCR products is necessary to differentiate AP-ha
and AP-Variant 1 and therefore to assess the potential for
human infections. These issues were not addressed in ear-
lier studies and likely resulted in overestimation of the
prevalence of AP-ha in nature and in the implied risk for
human anaplasmosis. Therefore, future studies of host or
vector populations must be evaluated and interpreted care-
fully, with the knowledge that non–disease-causing variant
strains may influence results.
While our results suggest that white-tailed deer are a
reservoir for AP-Variant 1, additional studies that examine
the interaction of AP-Variant 1 with white-tailed deer pop-
ulations in other parts of the United States are needed to
determine if they correspond to our results from
Pennsylvania. Differences in AP-Variant 1 strain composi-
tion or local white-tailed deer or I. scapularis tick popula-
tions may alter the interaction of the bacterial agent,
vector, and reservoir. AP-ha strains cause a transient, rela-
tively mild febrile illness with no overt signs of disease in
immunocompetent mouse species, including the natural
reservoir,  Peromyscus leucopus (13). Inbred laboratory
mice infected with AP-ha may remain infected for up to 55
days (6), and previous infections induce an immune
response that is only partially protective, since mice may
be reinfected (14). We have not determined whether AP-
Variant 1 produces any disease manifestation in white-
tailed deer, although the high number of positive deer in
the current study suggests that persistent infections, rein-
fections from feeding ticks, or both mechanisms may be
involved in maintenance of AP-Variant 1 in white-tailed
deer populations.
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botulism
Food poisoning with neurotoxicity caused by
eating food contaminated with Clostridium
botulinum. From the Latin botulus, "sausage,"
the disease was first recognized in Germany in
persons who had eaten tainted sausage and was
originally called "sausage poisoning."
Sources: Dorland's illustrated medical dictionary. 30th ed.
Philadelphia: Saunders; 2003 and Botulism in Alaska
[monograph on the Internet]. [cited 2005 Aug 26].
Available from http://www.epi.hss.state.ak.us/pubs/
botulism/bot_03.htm
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